Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer

PURPOSE: The outcome of radiotherapy (RT) for prostate cancer (PCA) depends on the delivered dose. While the evidence for dose-escalated RT up to 80 gray (Gy) is well established, there have been only few studies examining dose escalation above 80 Gy. We initiated the present study to assess the saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenbrock, Johannes, Baues, Christian, Kreis, Marius, Fouassi, Redouane, Celik, Eren, Paffenholz, Pia, Pfister, David, Heidenreich, Axel, Marnitz, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212800/
https://www.ncbi.nlm.nih.gov/pubmed/36930248
http://dx.doi.org/10.1007/s00066-023-02060-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212800/
https://www.ncbi.nlm.nih.gov/pubmed/36930248
http://dx.doi.org/10.1007/s00066-023-02060-2

Ejemplares similares